Edition:
India

Shire PLC (SHPG.OQ)

SHPG.OQ on NASDAQ Stock Exchange Global Select Market

160.08USD
1:30am IST
Change (% chg)

$-4.29 (-2.61%)
Prev Close
$164.37
Open
$160.29
Day's High
$161.47
Day's Low
$158.50
Volume
498,343
Avg. Vol
516,137
52-wk High
$192.15
52-wk Low
$123.73

Chart for

About

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas... (more)

Overall

Beta: 1.63
Market Cap(Mil.): $46,023.13
Shares Outstanding(Mil.): 302.84
Dividend: 0.15
Yield (%): 0.61

Financials

  SHPG.OQ Industry Sector
P/E (TTM): 66.53 30.95 32.74
EPS (TTM): 2.27 -- --
ROI: 1.15 14.84 14.38
ROE: 2.31 16.34 16.07

Japan's Takeda sweetens $62 billion Shire offer

TOKYO/LONDON Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals. | Video

20 Apr 2018

Japan's Takeda sweetens $62 billion Shire offer

TOKYO/LONDON Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals.

20 Apr 2018

UPDATE 4-Japan's Takeda sweetens $62 billion Shire offer

* Takeda makes fourth cash and shares bid at 47-pounds-a-share

20 Apr 2018

BRIEF-Shire Says Considering Position With Respect To Fourth Proposal From Takeda

* SHIRE PLC - STATEMENT RE PROPOSAL FROM TAKEDA PHARMACEUTICAL COMPANY LIMITED ("TAKEDA")

20 Apr 2018

UPDATE 1-FTSE 100 posts fourth straight week of gains while Reckitt, Shire fall

* Shire falls after Allergan rules out bid (Adds closing prices)

20 Apr 2018

Takeda ups Shire offer to 47 pounds-a-share

LONDON, April 20 Japan's Takeda Pharmaceutical Co Ltd increased its offer for Shire to 47 pounds a share on Friday after its three previous bids - the last at 46.50 pounds - were rejected by the rare disease drugs specialist.

20 Apr 2018

Takeda weighs raising Shire bid to more than 47 stg/share: sources

Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds ($66) per share or more, people familiar with the matter said on Friday.

20 Apr 2018

Takeda weighs raising Shire bid to more than 47 stg/share-sources

April 20 Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds ($66) per share or more, people familiar with the matter said on Friday.

20 Apr 2018

FTSE 100 set for fourth straight week of gains while Reckitt, Shire tumble

LONDON, April 20 Weaker sterling helped Britain's FTSE 100 outperform European markets on Friday, while consumer giant Reckitt Benckiser tumbled after disappointing results and Shire declined as Allergan pulled out of the running to acquire the company.

20 Apr 2018

BRIEF-Allergan confirms does not intend to make Shire

* ALLERGAN NOW CONFIRMS THAT IT DOES NOT INTEND TO MAKE AN OFFER FOR SHIRE Source text for Eikon: Further company coverage: (Reporting by Maiya Keidan)

20 Apr 2018

Earnings vs. Estimates